Klimeš, Filip
Kern, Agilo Luitger
Voskrebenzev, Andreas
Gutberlet, Marcel
Grimm, Robert
Müller, Robin Aaron
Behrendt, Lea
Kaireit, Till Frederik
Glandorf, Julian
Alsady, Tawfik Moher
Wacker, Frank
Hohlfeld, Jens M.
Vogel-Claussen, Jens https://orcid.org/0000-0001-5595-6948
Article History
Received: 23 February 2024
Revised: 17 April 2024
Accepted: 1 May 2024
First Online: 26 July 2024
Compliance with ethical standards
:
: The scientific guarantor of this publication is Jens Vogel-Claussen.
: Filip Klimeš, Andreas Voskrebenzev, and Jens Vogel-Claussen are shareholders in BioVisioneers GmbH, a company, which has an interest in pulmonary MRI methods. Robert Grimm is an employee of Siemens Healthcare GmbH, Erlangen, Germany.
: No complex statistical methods were necessary for this paper.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained. COPD patients were recruited under approval number 07423, while healthy volunteers were recruited under approval number 10020.
: None.
: